Question to the Department of Health and Social Care:

To ask Her Majesty’s Government what consideration they are giving to recent research by Professor Jeffrey Bluestone and others at the University of California on the immune system of those with type 1 diabetes; and whether funding will be made available to diabetes researchers in the UK to keep pace with such developments.

Research relating to immunotherapy for type 1 diabetes is being carried out by researchers at the University of California and at other institutions internationally. The National Institute for Health Research (NIHR) is funding research relating to immunotherapy for type 1 diabetes at the NIHR Cambridge Biomedical Research Centre. In addition, the NIHR funds a wide range of other research relating to diabetes.

The NIHR welcomes funding applications for research into any aspect of human health, including immunotherapy for type 1 diabetes. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.